BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 7600544)

  • 21. Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumor incidence in Wistar rats.
    Thorup I; Meyer O; Kristiansen E
    Nutr Cancer; 1994; 21(2):177-82. PubMed ID: 8058528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microsatellite instability in aberrant crypt foci from human colons.
    Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
    Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
    Whiteley LO; Hudson L; Pretlow TP
    Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer.
    Karthik Kumar V; Vennila S; Nalini N
    Food Chem Toxicol; 2009 Feb; 47(2):309-15. PubMed ID: 19056454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalent location of flat dysplastic aberrant crypt foci near lymphoid follicles in the colon of azoxymethane-treated rats.
    Paulsen JE; Steffensen IL; Olstørn HB; Alexander J
    Anticancer Res; 2006; 26(3A):1803-7. PubMed ID: 16827110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes.
    Winkelmann I; Diehl D; Oesterle D; Daniel H; Wenzel U
    Carcinogenesis; 2007 Jul; 28(7):1446-54. PubMed ID: 17347140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
    Femia AP; Dolara P; Caderni G
    Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats.
    Liu R; Xu G
    Food Chem Toxicol; 2008 Aug; 46(8):2672-9. PubMed ID: 18571825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies.
    Reddy BS
    Br J Nutr; 1998 Oct; 80(4):S219-23. PubMed ID: 9924288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat.
    Wargovich MJ; Chen CD; Jimenez A; Steele VE; Velasco M; Stephens LC; Price R; Gray K; Kelloff GJ
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):355-60. PubMed ID: 9162301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vanadium inhibits DNA-protein cross-links and ameliorates surface level changes of aberrant crypt foci during 1,2-dimethylhydrazine induced rat colon carcinogenesis.
    Kanna PS; Saralaya MG; Samanta K; Chatterjee M
    Cell Biol Toxicol; 2005 Jan; 21(1):41-52. PubMed ID: 15868487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deoxycholic acid promotes the growth of colonic aberrant crypt foci.
    Flynn C; Montrose DC; Swank DL; Nakanishi M; Ilsley JN; Rosenberg DW
    Mol Carcinog; 2007 Jan; 46(1):60-70. PubMed ID: 17091474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary sucrose and starch affect dysplastic characteristics in carcinogen-induced aberrant crypt foci in rat colon.
    Caderni G; Lancioni L; Luceri C; Giannini A; Lodovici M; Biggeri A; Dolara P
    Cancer Lett; 1997 Mar; 114(1-2):39-41. PubMed ID: 9103249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci.
    McLellan E; Bird RP
    Carcinogenesis; 1991 Jun; 12(6):969-72. PubMed ID: 2044203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats.
    Hambly RJ; Rumney CJ; Cunninghame M; Fletcher JM; Rijken PJ; Rowland IR
    Carcinogenesis; 1997 Aug; 18(8):1535-9. PubMed ID: 9276627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon.
    McLellan EA; Medline A; Bird RP
    Carcinogenesis; 1991 Nov; 12(11):2093-8. PubMed ID: 1934294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.